<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre=": Research Article Longitudinal seroepidemiologic study of the 2009 pandemic" exact="influenza" post="A (H1N1) infection among health care workers in a"/>
 <result pre="http://www.biomedcentral.com/1471-2334/12/89 Abstract Background To probe seroepidemiology of the 2009 pandemic" exact="influenza" post="A (H1N1) among health care workers (HCWs) in a"/>
 <result pre="HCWs in a children's hospital in Taipei before the 2009" exact="influenza" post="A (H1N1) pandemic, before H1N1 vaccination, and after the"/>
 <result pre="pandemic. HCWs who had come into direct contact with 2009" exact="influenza" post="A (H1N1) patients or their clinical respiratory samples during"/>
 <result pre="(12.0%) showed either virological or serological evidence of 2009 pandemic" exact="influenza" post="A (H1N1) infection. Of the 90 unvaccinated HCWs, baseline"/>
 <result pre="associated with seroconversion. Conclusion The infection rate of 2009 pandemic" exact="influenza" post="A (H1N1) in HCWs was moderate and not higher"/>
 <result pre="The majority of unvaccinated HCWs remained susceptible. Direct contact of" exact="influenza" post="patients and their respiratory samples increased the risk of"/>
 <result pre="April 2009 in the USA and Mexico, the 2009 pandemic" exact="influenza" post="A (H1N1) virus has caused significant morbidity and mortality"/>
 <result pre="[ 2]. Mechanisms of person-to-person transmission of the 2009 H1N1" exact="influenza" post="virus appear similar to those of seasonal influenza ["/>
 <result pre="2009 H1N1 influenza virus appear similar to those of seasonal" exact="influenza" post="[ 2]. In light of medical knowledge derived from"/>
 <result pre="taking care of sick children, run substantial risk of acquiring" exact="influenza" post="[ 3, 4]. To prevent transmission of 2009 H1N1"/>
 <result pre="influenza [ 3, 4]. To prevent transmission of 2009 H1N1" exact="influenza" post="in healthcare settings, US Centers for Disease Control and"/>
 <result pre="of 23 million, experienced two epidemic waves of 2009 pandemic" exact="influenza" post="A (H1N1) [ 6]. The first began in early"/>
 <result pre="blood samples to determine the seroprevalence of antibodies against 2009" exact="influenza" post="A (H1N1) among HCWs before, during, and after the"/>
 <result pre="A (H1N1) among HCWs before, during, and after the 2009-2010" exact="influenza" post="seasons in Taiwan. The study targeted the seroepidemiology of"/>
 <result pre="in Taiwan. The study targeted the seroepidemiology of 2009 pandemic" exact="influenza" post="A (H1N1) in HCWs, along with efficacy of personal"/>
 <result pre="or less coincided with the early phase of the 2009" exact="influenza" post="A (H1N1) epidemic in Taiwan. The second sample was"/>
 <result pre="peak and just before implementation of the monovalent 2009 pandemic" exact="influenza" post="A (H1N1) vaccination program. The third sample was collected"/>
 <result pre="Hemagglutination inhibition (HAI) assay determined antibody levels for 2009 pandemic" exact="influenza" post="A (H1N1). A questionnaire collected information on demographic data,"/>
 <result pre="on demographic data, history of influenza-like illnesses (ILI), history of" exact="influenza" post="vaccination, and PPE (mainly surgical masks) usage. An ILI"/>
 <result pre="isolation and real-time polymerase chain reaction (PCR) for 2009 pandemic" exact="influenza" post="A (H1N1) virus were immediately performed to confirm the"/>
 <result pre="were divided into two groups based on risk of contracting" exact="influenza" post="A (H1N1) infection. The high-risk group included staff that"/>
 <result pre="staff that would come into direct contact with 2009 pandemic" exact="influenza" post="A (H1N1) patients or their respiratory samples. This group"/>
 <result pre="During the study period, all ILI patients were tested for" exact="influenza" post="A and B viruses by rapid test (QuickVue Influenza"/>
 <result pre="when in direct contact with suspected or confirmed 2009 pandemic" exact="influenza" post="A (H1N1) patients. NTUCH offers annual trivalent, inactivated influenza"/>
 <result pre="pandemic influenza A (H1N1) patients. NTUCH offers annual trivalent, inactivated" exact="influenza" post="vaccines and supplied monovalent inactivated 2009 influenza A (H1N1)"/>
 <result pre="annual trivalent, inactivated influenza vaccines and supplied monovalent inactivated 2009" exact="influenza" post="A (H1N1) vaccines [ 9, 10] free of charge"/>
 <result pre="and infection control training courses were implemented during the 2009" exact="influenza" post="A (H1N1) pandemic. Determining 2009 pandemic influenza A (H1N1)"/>
 <result pre="during the 2009 influenza A (H1N1) pandemic. Determining 2009 pandemic" exact="influenza" post="A (H1N1) antibody Hemagglutination inhibition (HAI) assay determined antibody"/>
 <result pre="antibody Hemagglutination inhibition (HAI) assay determined antibody levels against 2009" exact="influenza" post="A/California/7/2009 A (H1N1). Drawn blood was centrifuged to separate"/>
 <result pre="10-fold dilution) serum was incubated with equal volume of A/California/07/2009" exact="influenza" post="virus containing 8 HA units for 30 minutes at"/>
 <result pre="titers between any successive paired sera. The diagnosis of 2009" exact="influenza" post="A (H1N1) infection was made based on positive viral"/>
 <result pre="or seroconversion detected in blood samples. Definition of 2009 pandemic" exact="influenza" post="A (H1N1) infection Laboratory diagnosis of H1N1 relied on"/>
 <result pre="from throat swabs, were defined as virologically confirmed 2009 pandemic" exact="influenza" post="A (H1N1) infections. Subjects having seroconversions were defined as"/>
 <result pre="seroconversions were defined as having serological evidence of 2009 pandemic" exact="influenza" post="A (H1N1) infection. Subjects with any of the above"/>
 <result pre="having laboratory evidence of H1N1 infection. Epidemiology of 2009 pandemic" exact="influenza" post="A (H1N1) in Taiwan In April 2009, the Taiwan"/>
 <result pre="2009, the Taiwan Center for Disease Control added 2009 pandemic" exact="influenza" post="A (H1N1) infection to its list of reportable diseases"/>
 <result pre="to show the number of confirmed cases of 2009 pandemic" exact="influenza" post="A (H1N1) infection from May 2009 to April 2010"/>
 <result pre="April 2010 in Taiwan. ILI episodes and laboratory-confirmed 2009 pandemic" exact="influenza" post="A (H1N1) infections in our study subjects were also"/>
 <result pre="(H1N1) infections in our study subjects were also compared against" exact="influenza" post="epidemic activity in Taiwan in the same figure by"/>
 <result pre="using these variables alongside baseline titer, age, sex, 2009 pandemic" exact="influenza" post="A vaccine status, high-risk group, ILI history, 2009 pandemic"/>
 <result pre="influenza A vaccine status, high-risk group, ILI history, 2009 pandemic" exact="influenza" post="infection history, optimal surgical mask usage, and hand hygiene"/>
 <result pre="status to gauge their contribution to seroconversion and 2009 pandemic" exact="influenza" post="A (H1N1) infection rates. Odds ratios (ORs) with asymptotic"/>
 <result pre="groups (59 participants) according to degree of exposure to 2009" exact="influenza" post="A (H1N1) in their working environment. Two participants in"/>
 <result pre="and its relationship with the epidemic waves of 2009 pandemic" exact="influenza" post="A (H1N1) infection from May 2009 to April 2010"/>
 <result pre="high-risk participants received 2009 inactivated trivalent seasonal and monovalent H1N1" exact="influenza" post="vaccination. Optimal surgical mask and hand hygiene were also"/>
 <result pre="of study subjects with influenza-like illness and laboratory-confirmed 2009 pandemic" exact="influenza" post="A (H1N1) infections were plotted over an epidemic curve"/>
 <result pre="were plotted over an epidemic curve of confirmed 2009 pandemic" exact="influenza" post="A (H1N1) cases in Taiwan . The first epidemic"/>
 <result pre="arrows indicate when a nationwide vaccination with monovalent 2009 pandemic" exact="influenza" post="A (H1N1) vaccine was implemented. Table 1 Demographics, vaccination"/>
 <result pre="care workers at a children's hospital during the 2009 H1N1" exact="influenza" post="pandemic in Taiwan Characteristics All (N = 150) No."/>
 <result pre="Male: Female 34:116 28:65 6:51 0.005 Vaccinated with 2009 seasonal" exact="influenza" post="vaccine 77 (51.3%) 60 (64.5%) 17 (29.8%) &amp;lt; 0.001"/>
 <result pre="77 (51.3%) 60 (64.5%) 17 (29.8%) &amp;lt; 0.001 2009 H1N1" exact="influenza" post="vaccine 60 (40.0%) 53 (57.0%) 7 (12.3%) &amp;lt; 0.001"/>
 <result pre="between high-risk and low-risk groups. Infection rates of 2009 pandemic" exact="influenza" post="A (H1N1) virus Figure 2 plots the temporal relation"/>
 <result pre="study subjects who have ILI or laboratory evidence of 2009" exact="influenza" post="A (H1N1) infections and statistics of laboratory-confirmed cases of"/>
 <result pre="A (H1N1) infections and statistics of laboratory-confirmed cases of 2009" exact="influenza" post="A (H1N1) nationwide. Nationwide, laboratory-confirmed 2009 influenza A (H1N1)"/>
 <result pre="cases of 2009 influenza A (H1N1) nationwide. Nationwide, laboratory-confirmed 2009" exact="influenza" post="A (H1N1) cases rose rapidly in August 2009 and"/>
 <result pre="participants had either virological or serological evidence of 2009 pandemic" exact="influenza" post="A (H1N1) infection before the second blood sampling. No"/>
 <result pre="including influenza-like illness (ILI), and laboratory evidence of 2009 pandemic" exact="influenza" post="A (H1N1) infections in 60 vaccinated with a monovalent"/>
 <result pre="(H1N1) infections in 60 vaccinated with a monovalent 2009 pandemic" exact="influenza" post="A(H1N1) vaccine and 90 unvaccinated healthcare workers at a"/>
 <result pre="at a children's hospital during and after 2009 acute H1N1" exact="influenza" post="pandemic in Taiwan All (N = 150) Vaccinated Unvaccinated"/>
 <result pre="real time polymerase chain reaction, or seroconversion, of 2009 pandemic" exact="influenza" post="A (H1N1) infection. 4 Virologically confirmed means either viral"/>
 <result pre="or real-time polymerase chain reaction was positive of 2009 pandemic" exact="influenza" post="(H1N1) virus. 5 With serological evidence with seroconversion or"/>
 <result pre="seroconversion or four fold rise of antibodies against 2009 pandemic" exact="influenza" post="(H1N1) virus. Of all HCWs, 30% (45/150) reported ILI"/>
 <result pre="out of 150 HCWs showed laboratory evidence of 2009 pandemic" exact="influenza" post="A (H1N1) infections. Among HCWs not vaccinated with the"/>
 <result pre="infections. Among HCWs not vaccinated with the monovalent 2009 H1N1" exact="influenza" post="vaccine (N = 90), fifteen (16.7%) had laboratory evidence"/>
 <result pre="evidence. Vaccinated HCWs had significantly lower incidence of 2009 H1N1" exact="influenza" post="infection with laboratory evidence than unvaccinated ones (5.0% vs."/>
 <result pre="the study, only fifteen (16.7%) showed laboratory evidence of H1N1" exact="influenza" post="infection. Unvaccinated high-risk HCWs had slightly higher chance of"/>
 <result pre="slightly higher chance of having laboratory evidence of 2009 H1N1" exact="influenza" post="infection than the low-risk group (25.0 and 10.0%, respectively);"/>
 <result pre="in serology analysis (Table 3); sixty received monovalent 2009 pandemic" exact="influenza" post="A (H1N1) vaccinations. Baseline and post pandemic seroprotective rates"/>
 <result pre="but no detectable seroconversion. Table 3 Results of 2009 pandemic" exact="influenza" post="A (H1N1) antibodies before and after the pandemic in"/>
 <result pre="and low-risk. Of the sixty HCWs who received monovalent H1N1" exact="influenza" post="vaccinations in November 2009, the pre-vaccination seroprotective rate was"/>
 <result pre="2010. Two participants (2/60, 3.3%) had virologically confirmed 2009 pandemic" exact="influenza" post="A (H1N1) infections within two weeks after vaccination. No"/>
 <result pre="(H1N1) infections within two weeks after vaccination. No 2009 H1N1" exact="influenza" post="infections were confirmed among this group after December 2009."/>
 <result pre="(Table 3). The proportion of HCWs who received monovalent 2009" exact="influenza" post="A (H1N1) vaccination was higher among high-risk than low-risk"/>
 <result pre="0.036) (Table 4). HCWs with ILI or virologically confirmed 2009" exact="influenza" post="A (H1N1) infection were significantly associated seroconversion. Factors such"/>
 <result pre="analysis. Multivariate analysis for risk factors of virologically confirmed 2009" exact="influenza" post="A (H1N1) infection in unvaccinated HCWs proved ILI episodes"/>
 <result pre="analyses for factors associated with total seroconversion for 2009 pandemic" exact="influenza" post="A (H1N1) in 90 unvaccinated healthcare workers at a"/>
 <result pre="3 HCWs in direct contact with patients with 2009 pandemic" exact="influenza" post="A (H1N1) infection or their respiratory samples were designated"/>
 <result pre="real time polymerase chain reaction was positive of 2009 H1N1" exact="influenza" post="virus. Discussion Since the worldwide pandemic of 2009 influenza"/>
 <result pre="H1N1 influenza virus. Discussion Since the worldwide pandemic of 2009" exact="influenza" post="A (H1N1) virus, studies on the risk of infection"/>
 <result pre="Yet studies on the prevalence and seroepidemiology of 2009 pandemic" exact="influenza" post="A (H1N1) in HCWs taking care of children remain"/>
 <result pre="between clinical versus non-clinical staff among 1,158 confirmed 2009 pandemic" exact="influenza" post="A (H1N1) infections in HCWs [ 15]. Current preventive"/>
 <result pre="samples presumably face higher risk. Nurses working in 2009 pandemic" exact="influenza" post="A (H1N1) isolation wards and coming in contact with"/>
 <result pre="[ 13]. Data confirmed high risk or direct contact with" exact="influenza" post="patients and their respiratory samples as independent risk factors"/>
 <result pre="were cited as effective as N95 respirators in preventing laboratory-confirmed" exact="influenza" post="infections [ 18, 19]. The World Health Organization recommends"/>
 <result pre="procedures. Reinforcement of current strategies is justified. Taiwan's first pandemic" exact="influenza" post="A (H1N1) infection was confirmed in May and remained"/>
 <result pre="previously thought. Our earlier study showed subjects vaccinated with seasonal" exact="influenza" post="vaccines unlikely to have cross reactivity to this virus"/>
 <result pre="this virus [ 20]. Another possibility is that the 2009" exact="influenza" post="A (H1N1) virus shared antigen similarities with older influenza"/>
 <result pre="2009 influenza A (H1N1) virus shared antigen similarities with older" exact="influenza" post="strains. Prevalence of cross-reactive antibodies to the 2009 influenza"/>
 <result pre="older influenza strains. Prevalence of cross-reactive antibodies to the 2009" exact="influenza" post="A (H1N1) virus in adults aged 18-60 were 0-13%"/>
 <result pre="coverage rate among HCWs is one priority in combating future" exact="influenza" post="epidemics. One US national health objective for 2010 was"/>
 <result pre="HCW vaccination coverage. Overall vaccination rates of monovalent 2009 pandemic" exact="influenza" post="A (H1N1) vaccines were about 70% for school age"/>
 <result pre="infection in any healthcare setting is quite low. Monovalent pandemic" exact="influenza" post="A (H1N1) vaccine in this study has immunogenicity of"/>
 <result pre="adults [ 9, 10]; data suggest rapid decline of vaccine-induced" exact="influenza" post="antibodies. A mere 56.7% (34/60) of vaccinees have detectable"/>
 <result pre="= 25) and those showing laboratory evidence of 2009 pandemic" exact="influenza" post="A (H1N1) infection (n = 15). Good serological studies"/>
 <result pre="suggests self-reported ILI as lacking specificity, especially during a major" exact="influenza" post="pandemic. Seasonal influenza H3N2 virus infections, plus other respiratory"/>
 <result pre="as lacking specificity, especially during a major influenza pandemic. Seasonal" exact="influenza" post="H3N2 virus infections, plus other respiratory viruses like rhinovirus"/>
 <result pre="and adenovirus co-circulated in the early stage of 2009 pandemic" exact="influenza" post="A (H1N1) in Taiwan. More than 86% of study"/>
 <result pre="offer reasonable protection but do not reduce the need for" exact="influenza" post="vaccination. Competing interests The authors declare that they have"/>
 <result pre="here: http://www.biomedcentral.com/1471-2334/12/89/prepub Acknowledgements Financial support: None reported. References Update: swine" exact="influenza" post="A (H1N1) infections--California and Texas, April 2009 MMWR Morb"/>
 <result pre="DS Kettner JD et al. Clinical aspects of pandemic 2009" exact="influenza" post="A (H1N1) virus infection N Engl J Med 2010"/>
 <result pre="control for care of patients with confirmed or suspected novel" exact="influenza" post="A (H1N1) virus infection in a healthcare setting. Centers"/>
 <result pre="Serological evidence of subclinical transmission of the 2009 pandemic H1N1" exact="influenza" post="virus outside of Mexico PLoS One 2011 6 1"/>
 <result pre="to assess the immunogenicity and safety of a monovalent 2009" exact="influenza" post="A (H1N1) vaccine in an area with low-level epidemics"/>
 <result pre="(H1N1) vaccine in an area with low-level epidemics of pandemic" exact="influenza" post="Vaccine 2010 28 45 7337 7343 10.1016/j.vaccine.2010.08.073 20817013 Lu"/>
 <result pre="and safety of a monovalent vaccine for the 2009 pandemic" exact="influenza" post="virus A (H1N1) in children and adolescents Vaccine 2010"/>
 <result pre="DK Ruben FL Gravenstein S Immunogenicity and safety of inactivated" exact="influenza" post="virus vaccine in young children in 2003-2004 Pediatr Infect"/>
 <result pre="Ho TS Wang SM Liu CC Historical review of pandemic" exact="influenza" post="A in Taiwan, 2009 Pediatr Neonatol 2010 51 2"/>
 <result pre="JT Peiris JS et al. Seroprevalence of antibody to pandemic" exact="influenza" post="A (H1N1) 2009 among healthcare workers after the first"/>
 <result pre="J Cui L Cook AR Laurie K et al. 2009" exact="influenza" post="A(H1N1) seroconversion rates and risk factors among distinct adult"/>
 <result pre="et al. Effectiveness of public health measures in mitigating pandemic" exact="influenza" post="spread: a prospective sero-epidemiological cohort study J Infect Dis"/>
 <result pre="for protection of health care personnel against pandemic novel swine-origin" exact="influenza" post="A (H1N1)-2009: results from an observational study Clin Infect"/>
 <result pre="S et al. Surgical mask vs N95 respirator for preventing" exact="influenza" post="among health care workers: a randomized trial JAMA 2009"/>
 <result pre="76 78 21192858 Serum cross-reactive antibody response to a novel" exact="influenza" post="A (H1N1) virus after vaccination with seasonal influenza vaccine"/>
 <result pre="a novel influenza A (H1N1) virus after vaccination with seasonal" exact="influenza" post="vaccine MMWR Morb Mortal Wkly Rep 2009 58 19"/>
 <result pre="et al. Cross-reactive antibody responses to the 2009 pandemic H1N1" exact="influenza" post="virus N Engl J Med 2009 361 20 1945"/>
 <result pre="Stanford E Andrews N Zambon M Incidence of 2009 pandemic" exact="influenza" post="A H1N1 infection in England: a cross-sectional serological study"/>
 <result pre="Julkunen I High frequency of cross-reacting antibodies against 2009 pandemic" exact="influenza" post="A(H1N1) virus among the elderly in Finland Euro Surveill"/>
</results>
